TY  - GEN
AU  - Kaufman,J-M
AU  - Palacios,S
AU  - Silverman,S
AU  - Sutradhar,S
AU  - Chines,A
TI  - An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX®
SN  - 1433-2965
PY  - 2014///0508
KW  - Aged
KW  - Aged, 80 and over
KW  - Algorithms
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Kaplan-Meier Estimate
KW  - Lumbar Vertebrae
KW  - physiopathology
KW  - Middle Aged
KW  - Osteoporosis, Postmenopausal
KW  - drug therapy
KW  - Osteoporotic Fractures
KW  - Raloxifene Hydrochloride
KW  - therapeutic use
KW  - Risk Assessment
KW  - methods
KW  - Spinal Fractures
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00198-013-2341-6
ER  -